Publications

1. Piñeros M, Lam CG, Mery L, Znaor A, Steliarova-Foucher E, Abraham N, et al. (2026). Building local capacity for childhood cancer registration: real-world examples. JCO Glob Oncol. 12(12):e2500471. https://doi.org/10.1200/GO-25-00471 PMID:41494142
2. Filho AM, Briganti A, Jemal A, Bray F (2025). Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. S0302-2838(25)04864-X. https://doi.org/10.1016/j.eururo.2025.12.011 PMID:41421927
3. Daltveit DS, Morgan E, Bardot A, Steliarova-Foucher E, Damie A, Hagenimana M, et al. (2025). Childhood cancer survival in Africa, Asia, Latin America and the Caribbean, during 2008–2017 (SURVCAN-3): a population-based benchmarking study of 16 821 children. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djaf321 PMID:41391483
4. Rumgay H, Colombet M, Ramos da Cunha A, Filho AM, Warnakulasuriya S, Conway DI, et al. (2026). Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. CA Cancer J Clin. 76(1):10.3322/caac.70048. https://doi.org/10.3322/caac.70048 PMID:41335400
5. Li M, Dal Maso L, Pizzato M, Rumgay H, Vaccarella S (2026). Thyroid cancer in adolescents and young adults: a population-based study in 185 countries worldwide. Lancet Diabetes Endocrinol. 14(2):112–22. https://doi.org/10.1016/S2213-8587(25)00289-X PMID:41274302
6. Vaccarella S, Vineis P (2025). Cancer care underuse, overuse, and inequalities. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djaf290 PMID:41059997
7. Kong YC, Niyigaba J, Tran PB, Vignat J, Bray F, Gauvreau CL, et al. (2025). Global paid and unpaid productivity losses due to cancer-related mortality. J Natl Cancer Inst. 117(12):2612–20. https://doi.org/10.1093/jnci/djaf193 PMID:40987468
8. Langselius O, Rumgay H, de Vries E, Whiteman DC, Jemal A, Parkin DM, et al. (2025). Global burden of cutaneous melanoma incidence attributable to ultraviolet radiation in 2022. Int J Cancer. 157(6):1110–9. https://doi.org/10.1002/ijc.35463 PMID:40421619
9. Valbuena-Garcia AM, Trujillo-Cáceres SJ, Hernández Vargas JA, Diaz S, Acuña L, Perdomo S, et al. (2025). Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort. Lancet Reg Health Am. 43:101018. https://doi.org/10.1016/j.lana.2025.101018 PMID:40171140
10. Znaor A, Fouad H, Zahwe M, Eser S, Fadhil I, Soerjomataram I, et al. (2025). Cancer surveillance in the Eastern Mediterranean region: a 10-year International Agency for Research on Cancer-WHO Regional Office for the Eastern Mediterranean collaboration. Lancet Oncol. 26(3):e131–9. https://doi.org/10.1016/S1470-2045(24)00624-7 PMID:40049204
11. Dee EC, Laversanne M, Bhoo-Pathy N, Ho FDV, Feliciano EJG, Eala MAB, et al. (2025). Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis. Lancet Oncol. 26(4):516–28. https://doi.org/10.1016/S1470-2045(25)00017-8 PMID:40024257
12. Luo G, Zhang Y, Rumgay H, Morgan E, Langselius O, Vignat J, et al. (2025). Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. Lancet Respir Med. 13(4):348–63. https://doi.org/10.1016/S2213-2600(24)00428-4 PMID:39914442
13. Shah R, Hanna NM, Loo CE, David M, Mafra A, Fink H, et al. (2025). The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis. Nat Cancer. 6(1):194–204. https://doi.org/10.1038/s43018-024-00880-4 PMID:39747650
14. Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. (2025). The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 156(7):1336–46. https://doi.org/10.1002/ijc.35278 PMID:39688499
15. da Cunha AR, Rumgay H, Vignat J, Laversanne M, Colombet M, Curado MP, et al. (2025). Global burden and international trends of laryngeal cancer incidence: a population-based study of recorded data and national estimates. Cancer Epidemiol. 99:102935. https://doi.org/10.1016/j.canep.2025.102935 PMID:40997398
16. Pizzato M, McCormack V, Dossus L, Al-Alem U, Delpierre C, Lamy S, et al. (2025). Education level and risk of breast cancer by tumor subtype in the EPIC cohort. Int J Cancer. 157(4):672–86. https://doi.org/10.1002/ijc.35413 PMID:40170258
17. Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, et al. (2024). Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25(11):1413–23. https://doi.org/10.1016/S1470-2045(24)00458-3 PMID:39393386
18. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3):229–63. https://doi.org/10.3322/caac.21834 PMID:38572751
19. Rey Brandariz J, Rumgay H, Ayo-Yusuf O, Edwards R, Islami F, Liu S, et al. (2024). Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study. Lancet Public Health. 9(10):e745–54. https://doi.org/10.1016/S2468-2667(24)00185-3 PMID:39366730
20. Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. (2024). Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study. BMJ. 386:e077738. [Erratum in: BMJ. 2024 Sep 11;386:q1995] https://doi.org/10.1136/bmj-2023-077738 PMID:39231588